• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

空腹状态下或早餐时口服液体左甲状腺素(LT4)后游离甲状腺素的循环浓度。

Circulating concentrations of free thyroxine after an oral intake of liquid LT4 taken either during fasting conditions or at breakfast.

作者信息

Marina Michela, Ceda Gian Paolo, Aloe Rosalia, Gnocchi Cecilia, Ceresini Graziano

机构信息

Department of Clinical and Experimental Medicine, University of Parma.

出版信息

Acta Biomed. 2016 Jan 16;87(3):247-252.

PMID:28112689
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10521879/
Abstract

BACKGROUND AND AIM OF THE WORK

Liquid levothyroxine (LT4) given at breakfast normalizes TSH in hypothyroid patients. However, a few studies are available on circulating free thyroxine (FT4) concentrations after liquid vs solid LT4 preparations.

METHODS

During an "ad interim" analysis on serum FT4 after 200 mcg liquid LT4 consumption while fasting in thyroidectomized thyroid cancer patients, we found that seven subjects fortuitously took liquid LT4 at breakfast. As established in the original protocol, serum FT4 was measured both at baseline as well as at 3 and 4 hours after solid or liquid LT4 consumption. We compared serum profile of FT4 in these subjects with those obtained in other subjects participating in the same study who took liquid LT4 (n. 7 subjects) or solid LT4 (n. 7 subjects) while fasting. The percentage increase of circulating FT4 was calculated at the above reported peak-times over the baseline values.

RESULTS

Circulating FT4 increased of about 40% in each group of subjects at both the 3rd and the 4th hour with no difference between these two time points in either group. The maximum FT4 % increase, irrespective of the time point, was 44.62 ± 3.05 (Mean ± SE), 44.84 ± 5.43, and 43.83 ± 1.30 after fasting solid, fasting liquid, and breakfast liquid LT4 consumption, respectively, with no differences among the three groups.

CONCLUSIONS

Circulating FT4 obtained after 3 and 4 hours from the ingestion of 200 mcg liquid LT4 is not influenced by meal and is comparable with that observed after solid LT4 preparations ingested while fasting.

摘要

工作背景与目的

早餐时服用液体左甲状腺素(LT4)可使甲状腺功能减退患者的促甲状腺激素(TSH)恢复正常。然而,关于液体与固体LT4制剂后循环游离甲状腺素(FT4)浓度的研究较少。

方法

在对甲状腺癌切除术后的患者空腹服用200μg液体LT4后的血清FT4进行“期中”分析时,我们发现7名受试者偶然在早餐时服用了液体LT4。按照原始方案,在基线以及服用固体或液体LT4后3小时和4小时测量血清FT4。我们将这些受试者的FT4血清谱与同一研究中其他空腹服用液体LT4(7名受试者)或固体LT4(7名受试者)的受试者的血清谱进行了比较。在上述报告的峰值时间计算循环FT4相对于基线值的增加百分比。

结果

每组受试者在第3小时和第4小时循环FT4均增加约40%,两组在这两个时间点之间均无差异。无论时间点如何,空腹服用固体LT4、空腹服用液体LT4和早餐时服用液体LT4后,FT4的最大增加百分比分别为44.62±3.05(平均值±标准误)、44.84±5.43和43.83±1.30,三组之间无差异。

结论

摄入200μg液体LT4后3小时和4小时获得的循环FT4不受进餐影响,与空腹服用固体LT4制剂后观察到的值相当。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58fc/10521879/7b4430a0217a/ACTA-87-247-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58fc/10521879/2ab746111881/ACTA-87-247-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58fc/10521879/7b4430a0217a/ACTA-87-247-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58fc/10521879/2ab746111881/ACTA-87-247-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58fc/10521879/7b4430a0217a/ACTA-87-247-g002.jpg

相似文献

1
Circulating concentrations of free thyroxine after an oral intake of liquid LT4 taken either during fasting conditions or at breakfast.空腹状态下或早餐时口服液体左甲状腺素(LT4)后游离甲状腺素的循环浓度。
Acta Biomed. 2016 Jan 16;87(3):247-252.
2
A Double-Blind Placebo-Controlled Trial of Liquid Thyroxine Ingested at Breakfast: Results of the TICO Study.早餐时服用液体甲状腺素的双盲安慰剂对照试验:TICO 研究结果。
Thyroid. 2016 Feb;26(2):197-202. doi: 10.1089/thy.2015.0422. Epub 2015 Dec 28.
3
TSH evaluation in hypothyroid patients assuming liquid levothyroxine at breakfast or 30 min before breakfast.评估早餐时或早餐前 30 分钟服用液体左甲状腺素的甲状腺功能减退症患者的 TSH。
J Endocrinol Invest. 2018 Nov;41(11):1301-1306. doi: 10.1007/s40618-018-0867-3. Epub 2018 Mar 26.
4
Levothyroxine-induced serum free thyroxine response following radioactive iodine administration in patients thyroidectomized for differentiated thyroid cancer: A randomized controlled trial.放射性碘治疗分化型甲状腺癌切除术后患者中左甲状腺素引起的血清游离甲状腺素反应:一项随机对照试验。
Endocrine. 2022 Aug;77(2):340-348. doi: 10.1007/s12020-022-03110-y. Epub 2022 Jun 25.
5
Optimal Timing of Thyroid Hormone Replacement During Ramadan Fasting: A Randomized Controlled Trial in Patients with Prior Total Thyroidectomy.甲状腺激素替代治疗在斋月禁食期间的最佳时机:一项在既往行甲状腺全切除术患者中的随机对照试验。
Thyroid. 2022 Sep;32(9):1029-1036. doi: 10.1089/thy.2022.0110. Epub 2022 Jul 27.
6
Shift from Levothyroxine Tablets to Liquid Formulation at Breakfast Improves Quality of Life of Hypothyroid Patients.早餐时将左甲状腺素片换成液体制剂可改善甲状腺功能减退患者的生活质量。
Endocr Metab Immune Disord Drug Targets. 2018;18(3):235-240. doi: 10.2174/1871530318666180125155348.
7
A Novel Levothyroxine Solution Results in Similar Bioavailability Whether Taken 30 or Just 15 Minutes Before a High-Fat High-Calorie Meal.一种新型左甲状腺素溶液,无论在高脂肪高热量餐前进食前 30 分钟还是 15 分钟服用,其生物利用度相似。
Thyroid. 2022 Aug;32(8):897-904. doi: 10.1089/thy.2021.0604. Epub 2022 May 23.
8
Role of levothyroxine supplementation in extremely low birth weight infants who have transient hypothyroidism without thyroid-stimulating hormone elevation.左甲状腺素补充剂在出生体重极低且患有无促甲状腺激素升高的短暂性甲状腺功能减退症婴儿中的作用。
Osaka City Med J. 2014 Jun;60(1):29-37.
9
Effect of timing of levothyroxine administration on the treatment of hypothyroidism: a three-period crossover randomized study.左甲状腺素给药时机对甲状腺功能减退症治疗效果的影响:三周期交叉随机研究。
Endocrine. 2018 Nov;62(2):432-439. doi: 10.1007/s12020-018-1686-1. Epub 2018 Jul 24.
10
Patient-Tailored Levothyroxine Dosage with Pharmacokinetic/Pharmacodynamic Modeling: A Novel Approach After Total Thyroidectomy.基于药代动力学/药效学模型的患者个体化左甲状腺素剂量调整:甲状腺全切除术后的一种新方法。
Thyroid. 2021 Sep;31(9):1297-1304. doi: 10.1089/thy.2021.0125. Epub 2021 Jun 22.

引用本文的文献

1
Therapeutic efficacy and patient compliance of levothyroxine liquid and softgel formulations taken with meals: a systematic review.左甲状腺素液体制剂和软胶囊制剂随餐服用的治疗效果及患者依从性:一项系统评价
Endocrine. 2025 Jan;87(1):48-58. doi: 10.1007/s12020-024-04016-7. Epub 2024 Aug 31.
2
Medications and Food Interfering with the Bioavailability of Levothyroxine: A Systematic Review.影响左甲状腺素生物利用度的药物与食物:一项系统评价
Ther Clin Risk Manag. 2023 Jun 23;19:503-523. doi: 10.2147/TCRM.S414460. eCollection 2023.
3
Levothyroxine: Conventional and Novel Drug Delivery Formulations.

本文引用的文献

1
Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study.左甲状腺素口服液与片剂用于无吸收不良的甲状腺功能减退患者:一项前瞻性研究。
Endocrine. 2016 Jun;52(3):597-601. doi: 10.1007/s12020-015-0836-y. Epub 2015 Dec 31.
2
A Double-Blind Placebo-Controlled Trial of Liquid Thyroxine Ingested at Breakfast: Results of the TICO Study.早餐时服用液体甲状腺素的双盲安慰剂对照试验:TICO 研究结果。
Thyroid. 2016 Feb;26(2):197-202. doi: 10.1089/thy.2015.0422. Epub 2015 Dec 28.
3
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
左甲状腺素:常规和新型药物制剂。
Endocr Rev. 2023 May 8;44(3):393-416. doi: 10.1210/endrev/bnac030.
4
An Overview on Different L-Thyroxine (l-T) Formulations and Factors Potentially Influencing the Treatment of Congenital Hypothyroidism During the First 3 Years of Life.不同左甲状腺素(l-T)制剂概述及可能影响生命最初 3 年先天性甲状腺功能减退症治疗的因素。
Front Endocrinol (Lausanne). 2022 Jun 9;13:859487. doi: 10.3389/fendo.2022.859487. eCollection 2022.
5
Seeking optimization of LT4 treatment in patients with differentiated thyroid cancer.寻求优化分化型甲状腺癌患者的 LT4 治疗。
Hormones (Athens). 2022 Dec;21(4):537-543. doi: 10.1007/s42000-022-00376-9. Epub 2022 Jun 2.
6
Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults.影响成人原发性甲状腺功能减退症激素替代治疗中左甲状腺素剂量的因素。
Rev Endocr Metab Disord. 2022 Jun;23(3):463-483. doi: 10.1007/s11154-021-09691-9. Epub 2021 Oct 20.
7
Levothyroxine Interactions with Food and Dietary Supplements-A Systematic Review.左甲状腺素与食物及膳食补充剂的相互作用——一项系统综述
Pharmaceuticals (Basel). 2021 Mar 2;14(3):206. doi: 10.3390/ph14030206.
8
Therapeutic Equivalence of a New Preparation of Liquid Levothyroxine with Tablets in Patients with Overt Primary Hypothyroidism.新型液体左甲状腺素制剂与片剂对明显原发性甲状腺功能减退症患者的治疗等效性
Eur Thyroid J. 2021 Mar;10(1):59-64. doi: 10.1159/000508216. Epub 2020 Jun 23.
9
Hypothyroidism in the Elderly: Who Should Be Treated and How?老年人甲状腺功能减退症:谁应接受治疗以及如何治疗?
J Endocr Soc. 2018 Nov 19;3(1):146-158. doi: 10.1210/js.2018-00207. eCollection 2019 Jan 1.
10
Levothyroxine Therapy: Changes of TSH Levels by Switching Patients from Tablet to Liquid Formulation. A Systematic Review and Meta-Analysis.左甲状腺素治疗:患者从片剂转换为液体制剂时促甲状腺激素水平的变化。一项系统评价与荟萃分析。
Front Endocrinol (Lausanne). 2018 Jan 26;9:10. doi: 10.3389/fendo.2018.00010. eCollection 2018.
2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南:美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
4
Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.甲状腺功能减退症治疗指南:由美国甲状腺协会甲状腺激素替代特别工作组制定。
Thyroid. 2014 Dec;24(12):1670-751. doi: 10.1089/thy.2014.0028.
5
Treatment with thyroid hormone.甲状腺激素治疗。
Endocr Rev. 2014 Jun;35(3):433-512. doi: 10.1210/er.2013-1083. Epub 2014 Jan 16.
6
Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism.甲状腺功能减退症中甲状腺激素替代治疗的范式转变。
Nat Rev Endocrinol. 2014 Mar;10(3):164-74. doi: 10.1038/nrendo.2013.258. Epub 2014 Jan 14.
7
When thyroid hormone replacement is ineffective?当甲状腺激素替代治疗无效时?
Curr Opin Endocrinol Diabetes Obes. 2013 Oct;20(5):467-77. doi: 10.1097/MED.0000000000000003.
8
Comparison between liquid and tablet formulations of levothyroxine in the initial treatment of congenital hypothyroidism.左甲状腺素液体剂型与片剂剂型在先天性甲状腺功能减退症初始治疗中的比较。
J Pediatr. 2013 Jun;162(6):1264-9, 1269.e1-2. doi: 10.1016/j.jpeds.2012.11.070. Epub 2013 Jan 11.
9
Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs. other available dosage forms.左甲状腺素新口服溶液与其他现有剂型相比的药代动力学及潜在优势。
Arzneimittelforschung. 2012 Dec;62(12):631-6. doi: 10.1055/s-0032-1329951. Epub 2012 Nov 15.
10
Improved levothyroxine pharmacokinetics after bariatric surgery.减重手术后左甲状腺素的药代动力学改善。
Thyroid. 2013 Apr;23(4):414-9. doi: 10.1089/thy.2011.0526. Epub 2013 Mar 18.